Literature DB >> 21190043

Renal function in pediatric cystic fibrosis patients in the first decade of life.

Chanel Prestidge1, Mark A Chilvers, A George F Davidson, Eva Cho, Vanessa McMahon, Colin T White.   

Abstract

With increasing life expectancy and the need for lung transplantation in the cystic fibrosis (CF) population, there are increasing reports of chronic kidney disease (CKD). However, values for baseline or longitudinal glomerular filtration rate (GFR) as measured by exogenous clearance markers are lacking in this population. Retrospective cross-sectional study in 2 to 18-year-olds cared for at a single CF center who had a GFR measured by plasma disappearance of Technetium-99 m diethylenetriaminepentaacetic acid (mGFR). The primary outcome was evidence of renal dysfunction as defined by CKD stage II or below (mGFR <90 ml/min/1.73 m(2), persistent abnormalities in urinary sediment, abnormal renal imaging). Of 63 patients evaluated, four had apparent renal dysfunction, one demonstrated decreased mGFR, and three others had persistent microscopic hematuria. The mean mGFR was substantially higher (140 ± 24 ml/min/1.73 m(2)) than expected or previously reported for healthy children. We did not demonstrate the presence of significant renal impairment after limited aminoglycoside exposure in the first decade following diagnosis with CF. However, we did document the presence of glomerular hyperfiltration in a significant proportion of our CF patients.

Entities:  

Mesh:

Year:  2010        PMID: 21190043     DOI: 10.1007/s00467-010-1737-1

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  48 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

Review 2.  Should proteinuria reduction be the criterion for antihypertensive drug selection for patients with kidney disease?

Authors:  Rigas G Kalaitzidis; George L Bakris
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-09       Impact factor: 2.894

3.  Increased renal clearance of cefsulodin due to higher glomerular filtration rate in cystic fibrosis.

Authors:  A Hedman; G Alván; B Strandvik; A Arvidsson
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

4.  Effect on renal function of essential fatty acid supplementation in cystic fibrosis.

Authors:  B Strandvik; U Berg; A Kallner; E Kusoffsky
Journal:  J Pediatr       Date:  1989-08       Impact factor: 4.406

Review 5.  Clinical evaluation of kidney function--glomerular function.

Authors:  J P Kassirer
Journal:  N Engl J Med       Date:  1971-08-12       Impact factor: 91.245

6.  Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use.

Authors:  M Al-Aloul; H Miller; S Alapati; P A Stockton; M J Ledson; M J Walshaw
Journal:  Pediatr Pulmonol       Date:  2005-01

7.  Renal histopathological lesions after lung transplantation in patients with cystic fibrosis.

Authors:  C Lefaucheur; D Nochy; C Amrein; P Chevalier; R Guillemain; M Cherif; C Jacquot; D Glotz; G S Hill
Journal:  Am J Transplant       Date:  2008-07-28       Impact factor: 8.086

8.  Serum fatty acid profiles in cystic fibrosis patients and their parents.

Authors:  A B Christophe; W J Warwick; R T Holman
Journal:  Lipids       Date:  1994-08       Impact factor: 1.880

Review 9.  Lung transplantation for cystic fibrosis.

Authors:  Paul A Corris
Journal:  Curr Opin Organ Transplant       Date:  2008-10       Impact factor: 2.640

View more
  4 in total

1.  Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Pulmonary Exacerbation in a Pediatric Cystic Fibrosis Patient.

Authors:  Leah Molloy; Ashley Hall Snyder; Ruma Srivastava; Michael J Rybak; Eric McGrath
Journal:  J Pediatr Pharmacol Ther       Date:  2014-04

Review 2.  Renal complications following lung and heart-lung transplantation.

Authors:  Paul D Robinson; Rukshana C Shroff; Helen Spencer
Journal:  Pediatr Nephrol       Date:  2012-06-24       Impact factor: 3.714

3.  Augmented renal clearance in pediatric intensive care: are we undertreating our sickest patients?

Authors:  Evelyn Dhont; Tatjana Van Der Heggen; Annick De Jaeger; Johan Vande Walle; Peter De Paepe; Pieter A De Cock
Journal:  Pediatr Nephrol       Date:  2018-10-29       Impact factor: 3.714

Review 4.  Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Drug Treatment of Non-Tuberculous Mycobacteria in Cystic Fibrosis.

Authors:  Andrew Burke; Daniel Smith; Chris Coulter; Scott C Bell; Rachel Thomson; Jason A Roberts
Journal:  Clin Pharmacokinet       Date:  2021-05-13       Impact factor: 5.577

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.